Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest

被引:515
|
作者
Pigny, P
Merlen, E
Robert, Y
Cortet-Rudelli, C
Decanter, C
Jonard, S
Dewailly, D
机构
[1] CHRU, Hop Jeanne Flandre, Dept Endocrine Gynaecol & Reprod Med, F-59037 Lille, France
[2] CHRU, Clin Marc Linquette, Lab Endocrinol, F-59037 Lille, France
[3] CHRU, Hop Jeanne Flandre, Dept Radiol, F-59037 Lille, France
[4] CHRU, Dept Diabetol & Endocrinol, F-59037 Lille, France
来源
关键词
D O I
10.1210/jc.2003-030727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The serum level of anti-Mullerian hormone (AMH), a product from granulosa cells involved in follicle growth, has been shown to correlate tightly with the small antral follicle number (FN) at ultrasonography (U/S) in women who do not have polycystic ovary syndrome ( PCOS). Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS. Serum AMH has been assayed in 104 women ( 59 symptomatic PCOS, 45 controls) between d 2 and 7 after the last either spontaneous or progestin-induced ( in PCOS) menstrual period. Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively). The ratio AMH/FN was similar between the two groups (4.8 +/- 3.4 vs. 4.8 +/- 2.9; P = 0.55). By simple regression, both in PCOS and controls, the AMH level was positively related to the 2- to 5-mm FN at U/S (P < 0.0001 and P < 0.03, respectively), but not to the 6- to 9-mm FN, and was negatively correlated to the serum FSH level ( P < 0.02 and P < 0.04, respectively). AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively ( P < 0.0005 and < 0.002, respectively). No relationship was found between AMH and age, serum estradiol, inhibin B, and LH levels in both groups. After multiple regression only the 2- to 5-mm FN remained significantly related to AMH in PCOS whereas testosterone, androstenedione, and FSH were no longer. In conclusion, the assay of the serum AMH may represent an important breakthrough in the diagnosis and in the understanding of PCOS. Our data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount of AMH. We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.
引用
收藏
页码:5957 / 5962
页数:6
相关论文
共 50 条
  • [21] Serum anti-Mullerian hormone as a predictive marker of polycystic ovarian syndrome
    Parco, Sergio
    Novelli, Caterina
    Vascotto, Fulvia
    Princi, Tanja
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2011, 4 : 759 - 763
  • [22] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Bhattacharya, Koushik
    Saha, Ishita
    Sen, Debanjana
    Bose, Chaitali
    Chaudhuri, Gargi Ray
    Dutta, Sulagna
    Sengupta, Pallav
    Bhattacharya, Soumita
    Barman, Sharit Shekhar
    Syamal, Alak Kumar
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2022, 27 (01)
  • [23] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Koushik Bhattacharya
    Ishita Saha
    Debanjana Sen
    Chaitali Bose
    Gargi Ray Chaudhuri
    Sulagna Dutta
    Pallav Sengupta
    Soumita Bhattacharya
    Sharit Shekhar Barman
    Alak Kumar Syamal
    Middle East Fertility Society Journal, 27
  • [24] Advantages of Serum Anti-Mullerian Hormone as a Marker for Polycystic Ovarian Syndrome
    Shi, Xinyan
    Peng, Duo
    Liu, Yanfei
    Miao, Xiaofen
    Ye, Hui
    Zhang, Jun
    LABORATORY MEDICINE, 2019, 50 (03) : 236 - 242
  • [25] Association between Anti-Mullerian Hormone and Ovarian Response and Pregnancy in Polycystic Ovary Syndrome Patients
    Ghomian, Nayereh
    Lotfalizadeh, Marzieh
    Afiat, Malihe
    Keshtan, Farideh Golhasani
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2019, 7 (01): : 49 - 53
  • [26] Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
    Sahmay, Sezai
    Atakul, Nil
    Oncul, Mahmut
    Tuten, Abdullah
    Aydogan, Begum
    Seyisoglu, Hakan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) : 157 - 161
  • [27] Determination of Ovarian Reserve with Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome and Premenopausal Women
    Inan, Cihan
    Yucel, Nese
    Isbilen, Banu
    Isman, Kemal Ferruh
    Bilgic, Ergun
    Ozer, Atinc
    JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2014, 4 (02): : 62 - 68
  • [28] Serum anti-Mullerian hormone levels and insulin resistance in polycystic ovary syndrome
    Makhlouf, R.
    Chaabouni, K.
    Charfi, A.
    Jallouli, D.
    Elleuch, A.
    Ayedi, F.
    CLINICA CHIMICA ACTA, 2022, 530 : S129 - S129
  • [29] Assessment of Anti-Mullerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
    Dursun, Fatma
    Guven, Ayla
    Yildiz, Metin
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2016, 8 (01) : 55 - 60
  • [30] The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
    Sivanandy, Mala S.
    Ha, Sierra K.
    DIAGNOSTICS, 2023, 13 (05)